Ditchcarbon
  • Contact
  1. Organizations
  2. Biontech
Public Profile
Pharmaceutical Preparation Manufacturing
DE
updated 8 days ago

Biontech

Company website

BioNTech SE, headquartered in Mainz, Germany, is a pioneering biotechnology company renowned for its innovative approach to immunotherapy. Founded in 2008, BioNTech has rapidly established itself as a leader in the development of personalised cancer treatments and infectious disease vaccines, notably its groundbreaking mRNA technology. The company gained global recognition for its collaboration with Pfizer in creating one of the first COVID-19 vaccines, marking a significant milestone in the fight against the pandemic. BioNTech's core offerings include mRNA-based therapeutics and vaccines, which are distinguished by their ability to elicit robust immune responses. With a strong market position and a commitment to advancing medical science, BioNTech continues to push the boundaries of biotechnology, aiming to transform patient care worldwide.

DitchCarbon Score

How does Biontech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

38

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Biontech's score of 38 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

59%

Let us know if this data was useful to you

Biontech's reported carbon emissions

In 2024, BioNTech SE reported total greenhouse gas emissions of approximately 892,897,000 kg CO2e. This figure includes 2,405,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 4,044,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The company also disclosed significant Scope 3 emissions, amounting to approximately 886,448,000 kg CO2e, which cover all other indirect emissions in the value chain. BioNTech has set ambitious climate commitments, aiming for a 42% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2030, using 2021 as the baseline year. This target aligns with the Science Based Targets initiative (SBTi) requirements, ensuring that their reduction efforts are consistent with the global goal of limiting temperature rise to 1.5°C. The company also commits that by 2027, 72% of its suppliers, based on emissions from purchased goods and services, capital goods, and upstream transportation and distribution, will have established science-based targets. In summary, BioNTech is actively working towards substantial emissions reductions while engaging its supply chain in climate action, reflecting a strong commitment to sustainability and environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
607,000
000,000
000,000
000,000
0,000,000
0,000,000
Scope 2
2,748,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
2,445,000
0,000,000
-
0,000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biontech's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Biontech is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biontech is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Mitsubishi Tanabe Pharma

JP
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Translate Bio, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251009.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy